Michael Burke, MD

Dr. Michael Burke is an Associate Professor at the Children’s Hospital of Wisconsin (CHW) in the Division of Hematology/Oncology/Blood & Marrow Transplantation. He is Director of the Pediatric Leukemia & Lymphoma Program at CHW and Co-Director of the Developmental Therapeutics Program where he oversees all early phase clinical trials clinical trials: Clinical research is at the heart of all medical advances, identifying new ways to prevent, detect or treat disease. If you have a bone marrow failure disease, you may want to consider taking part in a clinical trial, also called a research study. Understanding Clinical Trials Clinical… (Phase I and II studies) at CHW. He has developed both early phase and upfront clinical trials in acute leukemia that have opened locally here at CHW as well as nationally and internationally through consortiums such as the Children’s Oncology Group (COG) and the Therapeutic Advances in Childhood Leukemia & Lymphoma Consortium (TACL). Dr. Burke is the principal investigator of a Phase I trial for relapsed ALL and a phase I trial in relapsed AML both through the TACL consortium as well as study chair for the upfront COG trial for children with High-Risk and Very High-Risk B-cell ALL.